Ciuleanu, T., Berton, D., Daniele, G., Gales, L. N., Tosi, D., Curigliano, G., Lostes-Bardaji, M. J., Antonuzzo, L., Spéville, B. G. D. D., Volovat, C. D., Josephs, D., Montagud, G. S., Pinato, D. J., Ackroyd, S. A., Barrera, I., Preugschat, K., Grant, P. M., Hodgson, I., Smethurst, D., Loriot, Y. (2026). A phase 1/2 study of the next-generation nectin-4–targeting antibody-drug conjugate CRB-701 (SYS6002) in patients with recurrent or metastatic cervical cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5508